During the past decade, Centre Rétine Gallien conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Rétine Gallien" #1 collaborator was "Inferential" with 1 trials as a collaborator and "International Clinical Trials Association" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre Rétine Gallien" are "Cataract" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Retinopathy" (1 trials), "Macular Edema" (1 trials) and "Non-infectious Uveitis" (1 trials). Many other conditions were trialed in "Centre Rétine Gallien" in a lesser frequency.

Most popular intervention types in "Centre Rétine Gallien" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "I.SPACE®" (1 trials), "Ranibizumab 0.5mg" (1 trials), "Sham injection" (1 trials), "THR-317 8mg" (1 trials) and "dexamethasone intravitreal implant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Rétine Gallien" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centre Rétine Gallien". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Rétine Gallien, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Rétine Gallien, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".